160 related articles for article (PubMed ID: 38137344)
1. c-Met
Benkhoucha M; Tran NL; Senoner I; Breville G; Fritah H; Migliorini D; Dutoit V; Lalive PH
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137344
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel population of highly cytotoxic c-Met-expressing CD8
Benkhoucha M; Molnarfi N; Kaya G; Belnoue E; Bjarnadóttir K; Dietrich PY; Walker PR; Martinvalet D; Derouazi M; Lalive PH
EMBO Rep; 2017 Sep; 18(9):1545-1558. PubMed ID: 28751311
[TBL] [Abstract][Full Text] [Related]
3. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
[TBL] [Abstract][Full Text] [Related]
4. HLA-B-restricted, CD8+ cytolytic human T cell clones derived from a melanoma-invaded lymph node.
Nakashima M; Watanabe T; Koprowski H; Steplewski Z
Hybridoma; 1996 Apr; 15(2):147-54. PubMed ID: 8743295
[TBL] [Abstract][Full Text] [Related]
5. The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.
Benkhoucha M; Molnarfi N; Schneiter G; Walker PR; Lalive PH
J Neuroinflammation; 2013 Dec; 10():154. PubMed ID: 24344806
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice.
Verra NC; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; Weder P; Hooijberg E; Schumacher TN; Haanen JB; Spits H; Luiten RM
Cancer Res; 2004 Mar; 64(6):2153-61. PubMed ID: 15026357
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
8. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.
Nakagawa Y; Negishi Y; Shimizu M; Takahashi M; Ichikawa M; Takahashi H
Immunol Lett; 2015 Oct; 167(2):72-86. PubMed ID: 26209187
[TBL] [Abstract][Full Text] [Related]
9. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
10. c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells.
Benkhoucha M; Senoner I; Lalive PH
J Neuroinflammation; 2020 Feb; 17(1):68. PubMed ID: 32075650
[TBL] [Abstract][Full Text] [Related]
11. Rhesus Cytomegalovirus-Specific CD8
Rosen BC; Pedreño-Lopez N; Ricciardi MJ; Reed JS; Sacha JB; Rakasz EG; Watkins DI
Front Immunol; 2020; 11():1960. PubMed ID: 32922404
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen-Fibrin Gels by Cytolytic and Non-Lytic Mechanisms.
Majumder B; Budhu S; Ganusov VV
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515143
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.
Durgeau A; Virk Y; Corgnac S; Mami-Chouaib F
Front Immunol; 2018; 9():14. PubMed ID: 29403496
[TBL] [Abstract][Full Text] [Related]
14. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
15. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy.
Li C; Li W; Xiao J; Jiao S; Teng F; Xue S; Zhang C; Sheng C; Leng Q; Rudd CE; Wei B; Wang H
EMBO Mol Med; 2015 Jun; 7(6):754-69. PubMed ID: 25851535
[TBL] [Abstract][Full Text] [Related]
16. Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.
Celus W; Oliveira AI; Rivis S; Van Acker HH; Landeloos E; Serneels J; Cafarello ST; Van Herck Y; Mastrantonio R; Köhler A; Garg AD; Flamand V; Tamagnone L; Marine JC; Di Matteo M; Costa BM; Bechter O; Mazzone M
Cancer Immunol Res; 2022 Jan; 10(1):126-141. PubMed ID: 34815265
[TBL] [Abstract][Full Text] [Related]
17. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
18. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
[TBL] [Abstract][Full Text] [Related]
19. CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection.
Xu A; Wang R; Freywald A; Stewart K; Tikoo S; Xu J; Zheng C; Xiang J
Biochem Biophys Res Commun; 2017 Mar; 484(3):662-667. PubMed ID: 28153727
[TBL] [Abstract][Full Text] [Related]
20. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact.
Marijt WA; Veenhof WF; Goulmy E; Willemze R; van Rood JJ; Falkenburg JH
Blood; 1993 Dec; 82(12):3778-85. PubMed ID: 8260714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
